研究実績

Phase II study of a combination of docetaxel and irinotecan in patients with advanced/recurrent gastric cancer. Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG

Imamura H., Hiroshi Imamura, Hiroshi Furukawa, Hiroyuki Narahara, Kazumasa, Fujitani, Toshimasa Tsujinaka, Motohiro Imano, Kentaro Inoue, Seiichi, Sugihara: Phase II study of a combination of docetaxel and irinotecan in patients with advanced/recurrent gastric cancer. Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG: Protocol 0101. Clinical Investigators Update Meeting on Gastro-Intestinal Cance, Cheju Korea.

前の記事 次の記事 一覧ページへ戻る